Celldex Therapeutics | CLDX - Activos Circulantes





Activos Circulantes Cambio Fecha
AbbVie USD 33.53B 4.47B 2026-03
Agenus USD 95.28M 38.15M 2026-03
Amgen USD 31.48B 2.42B 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Celldex Therapeutics USD 459.22M 75.44M 2026-03
Glaxosmithkline GBP 23.59B 390.44M 2025-12
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Northwest Biotherapeutics USD 7.2M 1.04M 2025-09
Pfizer USD 42.82B 76M 2026-03
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Roche Holding CHF 38.73B 3.03B 2025-12